Cargando…
Identification & characterization of leucine-rich repeat kinase 2 & parkin RBR E3 ubiquitin protein ligase variants in patients with Parkinson's disease
BACKGROUND & OBJECTIVES: Parkinson's disease (PD) is a motor disorder that affects movement. More than 24 loci and 28 associated genes have been identified to be associated with this disease. The present study accounts for the contribution of two candidates, leucine-rich repeat kinase 2 (LR...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157902/ https://www.ncbi.nlm.nih.gov/pubmed/33707392 http://dx.doi.org/10.4103/ijmr.IJMR_730_18 |
_version_ | 1783699782723698688 |
---|---|
author | Halder, Tamali Verma, Shiv Prakash Raj, Janak Pandey, Sharad Singh, Ranjeet Kumar Sharma, Vivek Joshi, Deepika Das, Parimal |
author_facet | Halder, Tamali Verma, Shiv Prakash Raj, Janak Pandey, Sharad Singh, Ranjeet Kumar Sharma, Vivek Joshi, Deepika Das, Parimal |
author_sort | Halder, Tamali |
collection | PubMed |
description | BACKGROUND & OBJECTIVES: Parkinson's disease (PD) is a motor disorder that affects movement. More than 24 loci and 28 associated genes have been identified to be associated with this disease. The present study accounts for the contribution of two candidates, leucine-rich repeat kinase 2 (LRRK2) and parkin RBR E3 ubiquitin protein ligase (PRKN) in the PD patients, and their characterization in silico and in vitro. METHODS: A total of 145 sporadic PD cases and 120 ethnically matched healthy controls were enrolled with their informed consent. Mutation screening was performed by direct DNA sequencing of the targeted exons of LRRK2 and all exons flanking introns of PRKN. The effect of the pathogenic PRKN variants on a drug (MG-132) induced loss of mitochondrial membrane potential (△ΨM) was measured by a fluorescent dye tetramethylrhodamine methyl ester (TMRM). RESULTS: Twelve and 20 genetic variants were identified in LRRK2 and PRKN, respectively. Interestingly, five out of seven exonic LRRK2 variants were synonymous. Further assessment in controls confirmed the rarity of two such p.Y1527 and p.V1615. Among the pathogenic missense variations (as predicted in silico) in PRKN, two were selected (p.R42H and p.A82E) for their functional study in vitro, which revealed the reduced fluorescence intensity of TMRM as compared to wild type, in case of p.R42H but not the other. INTERPRETATION & CONCLUSIONS: About 6.2 per cent of the cases (9/145) in the studied patient cohort were found to carry pathogenic (as predicted in silico) missense variations in PRKN in heterozygous condition but not in case of LRRK2 which was rare. The presence of two rare synonymous variants of LRRK2 (p.Y1527 and p.V1615) may support the phenomenon of codon bias. Functional characterization of selected PRKN variations revealed p.R42H to cause disruption of mitochondrial membrane potential (△ΨM) rendering cells more susceptible to cellular stress. |
format | Online Article Text |
id | pubmed-8157902 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-81579022021-06-04 Identification & characterization of leucine-rich repeat kinase 2 & parkin RBR E3 ubiquitin protein ligase variants in patients with Parkinson's disease Halder, Tamali Verma, Shiv Prakash Raj, Janak Pandey, Sharad Singh, Ranjeet Kumar Sharma, Vivek Joshi, Deepika Das, Parimal Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Parkinson's disease (PD) is a motor disorder that affects movement. More than 24 loci and 28 associated genes have been identified to be associated with this disease. The present study accounts for the contribution of two candidates, leucine-rich repeat kinase 2 (LRRK2) and parkin RBR E3 ubiquitin protein ligase (PRKN) in the PD patients, and their characterization in silico and in vitro. METHODS: A total of 145 sporadic PD cases and 120 ethnically matched healthy controls were enrolled with their informed consent. Mutation screening was performed by direct DNA sequencing of the targeted exons of LRRK2 and all exons flanking introns of PRKN. The effect of the pathogenic PRKN variants on a drug (MG-132) induced loss of mitochondrial membrane potential (△ΨM) was measured by a fluorescent dye tetramethylrhodamine methyl ester (TMRM). RESULTS: Twelve and 20 genetic variants were identified in LRRK2 and PRKN, respectively. Interestingly, five out of seven exonic LRRK2 variants were synonymous. Further assessment in controls confirmed the rarity of two such p.Y1527 and p.V1615. Among the pathogenic missense variations (as predicted in silico) in PRKN, two were selected (p.R42H and p.A82E) for their functional study in vitro, which revealed the reduced fluorescence intensity of TMRM as compared to wild type, in case of p.R42H but not the other. INTERPRETATION & CONCLUSIONS: About 6.2 per cent of the cases (9/145) in the studied patient cohort were found to carry pathogenic (as predicted in silico) missense variations in PRKN in heterozygous condition but not in case of LRRK2 which was rare. The presence of two rare synonymous variants of LRRK2 (p.Y1527 and p.V1615) may support the phenomenon of codon bias. Functional characterization of selected PRKN variations revealed p.R42H to cause disruption of mitochondrial membrane potential (△ΨM) rendering cells more susceptible to cellular stress. Wolters Kluwer - Medknow 2020-11 /pmc/articles/PMC8157902/ /pubmed/33707392 http://dx.doi.org/10.4103/ijmr.IJMR_730_18 Text en Copyright: © 2021 Indian Journal of Medical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Halder, Tamali Verma, Shiv Prakash Raj, Janak Pandey, Sharad Singh, Ranjeet Kumar Sharma, Vivek Joshi, Deepika Das, Parimal Identification & characterization of leucine-rich repeat kinase 2 & parkin RBR E3 ubiquitin protein ligase variants in patients with Parkinson's disease |
title | Identification & characterization of leucine-rich repeat kinase 2 & parkin RBR E3 ubiquitin protein ligase variants in patients with Parkinson's disease |
title_full | Identification & characterization of leucine-rich repeat kinase 2 & parkin RBR E3 ubiquitin protein ligase variants in patients with Parkinson's disease |
title_fullStr | Identification & characterization of leucine-rich repeat kinase 2 & parkin RBR E3 ubiquitin protein ligase variants in patients with Parkinson's disease |
title_full_unstemmed | Identification & characterization of leucine-rich repeat kinase 2 & parkin RBR E3 ubiquitin protein ligase variants in patients with Parkinson's disease |
title_short | Identification & characterization of leucine-rich repeat kinase 2 & parkin RBR E3 ubiquitin protein ligase variants in patients with Parkinson's disease |
title_sort | identification & characterization of leucine-rich repeat kinase 2 & parkin rbr e3 ubiquitin protein ligase variants in patients with parkinson's disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157902/ https://www.ncbi.nlm.nih.gov/pubmed/33707392 http://dx.doi.org/10.4103/ijmr.IJMR_730_18 |
work_keys_str_mv | AT haldertamali identificationcharacterizationofleucinerichrepeatkinase2parkinrbre3ubiquitinproteinligasevariantsinpatientswithparkinsonsdisease AT vermashivprakash identificationcharacterizationofleucinerichrepeatkinase2parkinrbre3ubiquitinproteinligasevariantsinpatientswithparkinsonsdisease AT rajjanak identificationcharacterizationofleucinerichrepeatkinase2parkinrbre3ubiquitinproteinligasevariantsinpatientswithparkinsonsdisease AT pandeysharad identificationcharacterizationofleucinerichrepeatkinase2parkinrbre3ubiquitinproteinligasevariantsinpatientswithparkinsonsdisease AT singhranjeetkumar identificationcharacterizationofleucinerichrepeatkinase2parkinrbre3ubiquitinproteinligasevariantsinpatientswithparkinsonsdisease AT sharmavivek identificationcharacterizationofleucinerichrepeatkinase2parkinrbre3ubiquitinproteinligasevariantsinpatientswithparkinsonsdisease AT joshideepika identificationcharacterizationofleucinerichrepeatkinase2parkinrbre3ubiquitinproteinligasevariantsinpatientswithparkinsonsdisease AT dasparimal identificationcharacterizationofleucinerichrepeatkinase2parkinrbre3ubiquitinproteinligasevariantsinpatientswithparkinsonsdisease |